Posts tagged CRC
VolitionRx reports positive interim Nu.Q diagnostic results in colorectal cancer

VolitionRx (NYSE American:VNRX) announced interim results from its first asymptomatic colorectal cancer (CRC) frontline screening study in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark, with 680 subjects from the Danish National CRC Screening Program.

Read More